{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:22:31Z","timestamp":1791332551553,"version":"4.3.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T00:00:00Z","timestamp":1238025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00592-009-0112-9","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T12:38:58Z","timestamp":1237984738000},"page":"85-95","source":"Crossref","is-referenced-by-count":120,"title":["Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities"],"prefix":"10.1007","volume":"46","author":[{"given":"Eugenia","family":"Resmini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Minuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ferone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,26]]},"reference":[{"key":"112_CR1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0889-8529(05)70202-4","volume":"30","author":"A Ben-Shlomo","year":"2001","unstructured":"Ben-Shlomo A, Melmed S (2001) Acromegaly. Endocrinol Metab Clin North Am 30:565\u2013583","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl 2","key":"112_CR2","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/annonc\/12.suppl_2.S89","volume":"12","author":"M Doga","year":"2001","unstructured":"Doga M, Bonadonna S, Burattin A, Giustina A (2001) Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. Ann Oncol 12(Suppl 2):S89\u2013S94","journal-title":"Ann Oncol"},{"key":"112_CR3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1385\/EP:17:3:291","volume":"17","author":"F Salehi","year":"2006","unstructured":"Salehi F, Cohen S, Syro LV, Uribe H, Horvath E, Kovacs K, Asa SL (2006) Plurihormonality in pituitary adenomas associated with acromegaly. Endocr Pathol 17:291\u2013296","journal-title":"Endocr Pathol"},{"key":"112_CR4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1365-2265.2001.01080.x","volume":"54","author":"D Ferone","year":"2001","unstructured":"Ferone D, Pivonello R, Lastoria S, Faggiano A, Del Basso de Caro ML, Cappabianca P, Lombardi G, Colao A (2001) In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy. Clin Endocrinol (Oxf) 54:469\u2013477","journal-title":"Clin Endocrinol (Oxf)"},{"key":"112_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","volume":"12","author":"L Alexander","year":"1980","unstructured":"Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 12:71\u201379","journal-title":"Clin Endocrinol"},{"key":"112_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","volume":"223","author":"BA Bengtsson","year":"1988","unstructured":"Bengtsson BA, Ed\u00e9n S, Ernest I, Od\u00e9n A, Sj\u00f6gren B (1988) Epidemiology, long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327\u2013335","journal-title":"Acta Med Scand"},{"key":"112_CR7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","volume":"89","author":"IM Holdaway","year":"2004","unstructured":"Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667\u2013674","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR8","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","volume":"89","author":"J Ayuk","year":"2004","unstructured":"Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89:1613\u20131617","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 5","key":"112_CR9","first-page":"166","volume":"68","author":"IM Holdaway","year":"2007","unstructured":"Holdaway IM (2007) Excess mortality in acromegaly. Horm Res 68(Suppl 5):166\u2013172","journal-title":"Horm Res"},{"key":"112_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102\u2013152","journal-title":"Endocr Rev"},{"key":"112_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1987.tb00805.x","volume":"26","author":"JDN Nabarro","year":"1987","unstructured":"Nabarro JDN (1987) Acromegaly. Clin Endocrinol (Oxf) 26:481\u2013512","journal-title":"Clin Endocrinol (Oxf)"},{"key":"112_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1563-2571.2000.00106.x","volume":"27","author":"H Biering","year":"2000","unstructured":"Biering H, Knappe G, Gerl H, Lochs H (2000) Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Austriaca 27:27\u201331","journal-title":"Acta Med Austriaca"},{"key":"112_CR13","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1590\/S0100-879X2001001100009","volume":"34","author":"A Kreze","year":"2001","unstructured":"Kreze A, Kreze-Spirova E, Mikulecky M (2001) Risk factors for glucose intolerance in active acromegaly. Braz J Med Biol Res 34:1429\u20131433","journal-title":"Braz J Med Biol Res"},{"key":"112_CR14","first-page":"2709","volume":"54","author":"S Suzuki","year":"1996","unstructured":"Suzuki S (1996) Diabetes secondary to endocrinolopathies. Nippon Rinsho 54:2709\u20132714","journal-title":"Nippon Rinsho"},{"key":"112_CR15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0929-6646(08)60042-X","volume":"106","author":"YL Chen","year":"2007","unstructured":"Chen YL, Wei CP, Lee CC, Chang TC (2007) Diabetic ketoacidosis in a patient with acromegaly. J Formos Med Assoc 106:788\u2013791","journal-title":"J Formos Med Assoc"},{"key":"112_CR16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1445-5994.2002.00149.x","volume":"32","author":"HA Tran","year":"2002","unstructured":"Tran HA, Petrovsky N, Field AJ (2002) Severe diabetic retinopathy: a rare complication of acromegaly. Intern Med J 32:52\u201354","journal-title":"Intern Med J"},{"key":"112_CR17","first-page":"193","volume":"85","author":"A Colao","year":"2000","unstructured":"Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G, Liuzzi A (2000) Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 85:193\u2013199","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR18","first-page":"430","volume":"15","author":"B Larijani","year":"2005","unstructured":"Larijani B, Nakhjavani M, Baradar-Jalili R, Akrami SM, Bandarian F (2005) Diabetes mellitus following pituitary adenomectomy in euglycaemic patients with acromegaly. J Coll Physicians Surg Pak 15:430\u2013432","journal-title":"J Coll Physicians Surg Pak"},{"key":"112_CR19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2265.2003.01876.x","volume":"59","author":"R Baldelli","year":"2003","unstructured":"Baldelli R, Battista C, Leonetti F, Ghiggi MR, Ribaudo MC, Paoloni A, D\u2019Amico E, Ferretti E, Baratta R, Liuzzi A, Trischitta V, Tamburrano G (2003) Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogueues treatment. Clin Endocrinol (Oxf) 59:492\u2013499","journal-title":"Clin Endocrinol (Oxf)"},{"key":"112_CR20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1530\/eje.0.1300581","volume":"130","author":"BL Koop","year":"1994","unstructured":"Koop BL, Harris AG, Ezzat S (1994) Effect of octreotide on glucose tolerance in acromegaly. Eur J Endocrinol 130:581\u2013586","journal-title":"Eur J Endocrinol"},{"key":"112_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/jc.2005-1704","volume":"91","author":"CL Ronchi","year":"2006","unstructured":"Ronchi CL, Varca V, Beck-Peccoz P, Orsi E, Donadio F, Baccarelli A, Giavoli C, Ferrante E, Lania A, Spada A, Arosio M (2006) Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors. J Clin Endocrinol Metab 91:121\u2013128","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/jc.2008-1546","volume":"94","author":"A Colao","year":"2009","unstructured":"Colao A, Auriemma RS, Galdiero M, Cappabianca P, Cavallo LM, Esposito F, Grasso LF, Lombardi G, Pivonello R (2009) Impact of somatostatin analogs vs. surgery on glucose metabolism in acromegaly: results of a 5\u00a0years observational, open, prospective study. J Clin Endocrinol Metab 94:528\u2013537","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1210\/jc.2007-1197","volume":"93","author":"R Baldelli","year":"2008","unstructured":"Baldelli R, De Marinis L, Bianchi A, Pivonello R, Gasco V, Auriemma R, Pasimeni G, Cimino V, Appetecchia M, Maccario M, Lombardi G, Pontecorvi A, Colao A, Grottoli S (2008) Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. J Clin Endocrinol Metab 93:710\u2013714","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1385\/ENDO:28:1:111","volume":"28","author":"AN Paisley","year":"2005","unstructured":"Paisley AN, Drake WM (2005) Treatment of pituitary tumors: pegvisomant. Endocrine 28:111\u2013114","journal-title":"Endocrine"},{"key":"112_CR25","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1210\/jc.2005-0331","volume":"90","author":"AL Barkan","year":"2005","unstructured":"Barkan AL, Burman P, Clemmons DR, Drake WM, Gagel RF, Harris PE, Trainer PJ, van der Lely AJ, Vance ML (2005) Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant. J Clin Endocrinol Metab 90:5684\u20135691","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ecl.2007.10.010","volume":"37","author":"R Pivonello","year":"2008","unstructured":"Pivonello R, De Martino MC, De Leo M, Lombardi G, Colao A (2008) Cushing\u2019s syndrome. Endocrinol Metab Clin North Am 37:135\u2013149","journal-title":"Endocrinol Metab Clin North Am"},{"key":"112_CR27","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","volume":"88","author":"A Faggiano","year":"2003","unstructured":"Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1\u00a0year after disease remission. J Clin Endocrinol Metab 88:2527\u20132533","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR28","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1210\/jc.2004-0079","volume":"89","author":"M Terzolo","year":"2004","unstructured":"Terzolo M, Allasino B, Bosio S, Brusa E, Daffara F, Ventura M, Aroasio E, Sacchetto G, Reimondo G, Angeli A, Camaschella C (2004) Hyperhomocysteinemia in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 89:3745\u20133751","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR29","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","volume":"87","author":"L Tauchmanov\u00e0","year":"2002","unstructured":"Tauchmanov\u00e0 L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G (2002) Patients with subclinical Cushing\u2019s syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87:4872\u20134878","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00004872-198708000-00007","volume":"5","author":"JM Connell","year":"1987","unstructured":"Connell JM, Whitworth JA, Davies DL, Lever AF, Richards AM, Fraser R (1987) Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal functio in normal man. J Hypertens 5:425\u2013433","journal-title":"J Hypertens"},{"key":"112_CR31","first-page":"2664","volume":"84","author":"A Colao","year":"1999","unstructured":"Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G (1999) Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J Clin Endocrinol Metab 84:2664\u20132672","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF03345601","volume":"31","author":"I Chiodini","year":"2008","unstructured":"Chiodini I, Torlontano M, Carnevale V, Trischitta V, Scillitani A (2008) Skeletal involvement in adult patients with endogenous hypercortisolism. J Endocrinol Invest 31:267\u2013276","journal-title":"J Endocrinol Invest"},{"key":"112_CR33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11102-005-1172-7","volume":"7","author":"G Arnaldi","year":"2004","unstructured":"Arnaldi G, Mancini T, Polenta B, Boscaro M (2004) Cardiovascular risk in Cushing\u2019s syndrome. Pituitary 7:253\u2013256","journal-title":"Pituitary"},{"key":"112_CR34","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1210\/jc.2003-030254","volume":"88","author":"B Catargi","year":"2003","unstructured":"Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A (2003) Occult Cushing\u2019s syndrome in type-2 diabetes. J Clin Endocrinol Metab 88:5808\u20135813","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0950-351X(05)80169-7","volume":"6","author":"JE Nestler","year":"1992","unstructured":"Nestler JE, McClanahan MA (1992) Diabetes and adrenal disease. Baillieres Clin Endocrinol Metab 6:829\u2013847","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"112_CR36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/0961203307081113","volume":"16","author":"MB Urowitz","year":"2007","unstructured":"Urowitz MB, Gladman D, Iba\u00f1ez D, Fortin P, Sanchez-Guerrero J, Bae S, Clarke A, Bernatsky S, Gordon C, Hanly J, Wallace D, Isenberg D, Ginzler E, Merrill J, Alarcon G, Steinsson K, Petri M, Dooley MA, Bruce I, Manzi S, Khamashta M, Ramsey-Goldman R, Zoma A, Sturfelt G, Nived O, Maddison P, Font J, van Vollenhoven R, Aranow C, Kalunian K, Stoll T, Buyon J (2007) Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus 16:731\u2013735","journal-title":"Lupus"},{"key":"112_CR37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/pbc.20752","volume":"47","author":"C Meier","year":"2006","unstructured":"Meier C, Kapellen T, Tr\u00f6bs RB, Hirsch W, Parwaresch R, Kiess W, K\u00f6rholz D (2006) Temporary diabetes mellitus secondary to a primary pancreatic Burkitt lymphoma. Pediatr Blood Cancer 47:94\u201396","journal-title":"Pediatr Blood Cancer"},{"key":"112_CR38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2265.2008.03283.x","volume":"69","author":"M Steffens","year":"2008","unstructured":"Steffens M, Beauloye V, Brichard B, Robert A, Alexopoulou O, Ch Vermylen, Maiter D (2008) Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin Endocrinol (Oxf) 69:819\u2013827","journal-title":"Clin Endocrinol (Oxf)"},{"key":"112_CR39","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/pbc.21505","volume":"50","author":"JR Roberson","year":"2008","unstructured":"Roberson JR, Raju S, Shelso J, Pui CH, Howard SC (2008) Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 50:1207\u20131212","journal-title":"Pediatr Blood Cancer"},{"key":"112_CR40","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/jnci\/djn275","volume":"100","author":"IM Modlin","year":"2008","unstructured":"Modlin IM, Moss SF, Chung DC, Jensen RT, Snyderwine E (2008) Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst 100:1282\u20131289","journal-title":"J Natl Cancer Inst"},{"key":"112_CR41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"IM Modlin","year":"2008","unstructured":"Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9:61\u201372","journal-title":"Lancet Oncol"},{"key":"112_CR42","first-page":"61","volume-title":"Histological typing of endocrine tumours. WHO international classification of tumours","author":"E Solcia","year":"1999","unstructured":"Solcia E, Kloppel G, Sobin LH (1999) Histological typing of endocrine tumours. WHO international classification of tumours, 2nd edn. Springer, Berlin, pp 61\u201367","edition":"2"},{"key":"112_CR43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cncr.23549","volume":"113","author":"UF Pape","year":"2008","unstructured":"Pape UF, Jann H, M\u00fcller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, R\u00f6cken C, Rindi G, Wiedenmann B (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256\u2013265","journal-title":"Cancer"},{"key":"112_CR44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2008.03.001","volume":"37","author":"C Jim\u00e9nez","year":"2008","unstructured":"Jim\u00e9nez C, Hu MI, Gagel RF (2008) Management of medullary thyroid carcinoma. Endocrinol Metab Clin North Am 37:481\u2013496","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl 1","key":"112_CR45","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.nucmedbio.2008.04.007","volume":"35","author":"I Ilias","year":"2008","unstructured":"Ilias I, Pacak K (2008) A clinical overview of pheochromocytomas\/paragangliomas and carcinoid tumors. Nucl Med Biol 35(Suppl 1):S27\u2013S34","journal-title":"Nucl Med Biol"},{"key":"112_CR46","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/jc.2003-030000","volume":"88","author":"TD Wiesner","year":"2003","unstructured":"Wiesner TD, Bl\u00fcher M, Windgassen M, Paschke R (2003) Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. J Clin Endocrinol Metab 88:3632\u20133636","journal-title":"J Clin Endocrinol Metab"},{"key":"112_CR47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-8227(01)00261-3","volume":"54","author":"C Ishii","year":"2001","unstructured":"Ishii C, lnoue K, Negishi K, Tane N, Awata T, Katayama S (2001) Diabetic ketoacidosis in a case of pheochromocytoma. Diabetes Res Clin Pract 54:137\u2013142","journal-title":"Diabetes Res Clin Pract"},{"key":"112_CR48","first-page":"33","volume":"1","author":"VZ Schusdziarra","year":"1999","unstructured":"Schusdziarra VZ (1999) Glucagonoma-somatostatinoma. Gastroenterol Suppl 1:33\u201335","journal-title":"Gastroenterol Suppl"},{"key":"112_CR49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00268-005-0382-5","volume":"31","author":"JD Allendorf","year":"2007","unstructured":"Allendorf JD, Schrope BA, Lauerman MH, Inabnet WB, Chabot JA (2007) Postoperative glycaemic control after central pancreatectomy for mid-gland lesions. World J Surg 31:164\u2013168","journal-title":"World J Surg"},{"key":"112_CR50","doi-asserted-by":"crossref","unstructured":"Oberg K, Kaltsas G, Ferone D, Pl\u00f6ckinger U (2008) Standards of care in neuroendocrine tumors: biotherapy. neuroendocrinology. Dec 11 (epub ahead of print)","DOI":"10.1159\/000183751"},{"key":"112_CR51","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1210\/jc.2002-021260","volume":"88","author":"F Monaco","year":"2003","unstructured":"Monaco F (2003) Classification of thyroid diseases: suggestions for a revision. J Clin Endocrinol Metab 88:1428\u20131432","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 5","key":"112_CR52","first-page":"S133","volume":"89","author":"W Roubsanthisuk","year":"2006","unstructured":"Roubsanthisuk W, Watanakejorn P, Tunlakit M, Sriussadaporn S (2006) Hyperthyroidism induces glucose intolerance by lowering both insulin secretion and peripheral insulin sensitivity. J Med Assoc Thai 89(Suppl 5):S133\u2013S140","journal-title":"J Med Assoc Thai"},{"key":"112_CR53","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.6.5.512","volume":"6","author":"M Mouradian","year":"1983","unstructured":"Mouradian M, Abourizk N (1983) Diabetes mellitus and thyroid disease. Diabetes Care 6:512\u2013520","journal-title":"Diabetes Care"},{"key":"112_CR54","first-page":"119","volume":"4","author":"HP Himsworth","year":"1939","unstructured":"Himsworth HP, Kerr RB (1939) Insulin-sensitive and insulin insensitive types of diabetes mellitus. Clin Sci 4:119\u2013152","journal-title":"Clin Sci"},{"key":"112_CR55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, Association American Diabetes, Association European, for Study of Diabetes (2009) Medical management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32:193\u2013203","journal-title":"Diabetes Care"},{"key":"112_CR56","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM198805123181903","volume":"318","author":"KS Polonsky","year":"1988","unstructured":"Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E (1988) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318:1231\u20131239","journal-title":"N Engl J Med"},{"key":"112_CR57","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","volume":"44","author":"U.K. prospective diabetes study 16","year":"1995","unstructured":"U.K. prospective diabetes study 16 (1995) Overview of 6\u00a0years\u2019 therapy of type II diabetes: a progressive disease. Diabetes 44:1249\u20131258","journal-title":"Diabetes"},{"key":"112_CR58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1463-1326.1999.00015.x","volume":"1","author":"B Glaser","year":"1999","unstructured":"Glaser B, Cerasi E (1999) Early intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetes. Diabetes Obes Metab 1:67\u201374","journal-title":"Diabetes Obes Metab"},{"key":"112_CR59","first-page":"489","volume":"70","author":"JA Mayfield","year":"2004","unstructured":"Mayfield JA, White RD (2004) Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function. Am Fam Physician 70:489\u2013500","journal-title":"Am Fam Physician"},{"key":"112_CR60","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0149-2918(03)80156-X","volume":"25","author":"F Wang","year":"2003","unstructured":"Wang F, Carabino JM, Vergara CM (2003) Insulin glargine: a systemic review of a long-acting insulin analogue. Clin Ther 25:1541\u20131577","journal-title":"Clin Ther"},{"key":"112_CR61","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-130-5-199903020-00002","volume":"130","author":"H Yki-J\u00e4rvinen","year":"1999","unstructured":"Yki-J\u00e4rvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkil\u00e4 M (1999) Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 130:389\u2013396","journal-title":"Ann Intern Med"},{"key":"112_CR62","first-page":"108","volume-title":"Current therapy of diabetes mellitus","author":"JS Skyler","year":"1998","unstructured":"Skyler JS (1998) Insulin therapy in type 2 diabetes mellitus. In: DeFronzo RA (ed) Current therapy of diabetes mellitus. Mosby, St. Louis, pp 108\u2013116"},{"key":"112_CR63","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P Gaede","year":"2003","unstructured":"Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383\u2013393","journal-title":"N Engl J Med"},{"key":"112_CR64","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2337\/diacare.25.10.1691","volume":"25","author":"SM Strowig","year":"2002","unstructured":"Strowig SM, Aviles-Santa ML, Raskin P (2002) Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes. Diabetes Care 25:1691\u20131698","journal-title":"Diabetes Care"},{"key":"112_CR65","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2337\/diacare.28.4.950","volume":"28","author":"J Rosenstock","year":"2005","unstructured":"Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A (2005) Reduced hypoglycemia risk with insulin glargine A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 28:950\u2013955","journal-title":"Diabetes Care"},{"key":"112_CR66","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199707173370307","volume":"337","author":"F Holleman","year":"1997","unstructured":"Holleman F, Hoekstra JB (1997) Insulin lispro. N Engl J Med 337:176\u2013183","journal-title":"N Engl J Med"},{"key":"112_CR67","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2337\/diabetes.49.12.2142","volume":"49","author":"M Lepore","year":"2000","unstructured":"Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB (2000) Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analogue glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49:2142\u20132148","journal-title":"Diabetes"},{"key":"112_CR68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12325-008-0043-9","volume":"25","author":"S Leichter","year":"2008","unstructured":"Leichter S (2008) Is the use of insulin analogues cost-effective? Adv Ther 25:285\u2013299","journal-title":"Adv Ther"},{"key":"112_CR69","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1463-1326.2008.00874.x","volume":"10","author":"RH Becker","year":"2008","unstructured":"Becker RH, Frick AD, Teichert L, Nosek L, Heinemann L, Heise T, Rave K (2008) Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects. Diabetes Obes Metab 10:1105\u20131113","journal-title":"Diabetes Obes Metab"},{"key":"112_CR70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1463-1326.2006.00593.x","volume":"9","author":"SA Schreiber","year":"2007","unstructured":"Schreiber SA, Haak T (2007) Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12, 216 patients. Diabetes Obes Metab 9:31\u201338","journal-title":"Diabetes Obes Metab"},{"key":"112_CR71","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2165\/00003495-200363160-00007","volume":"63","author":"CJ Dunn","year":"2003","unstructured":"Dunn CJ, Plosker GL, Keating GM, McKeage K, Scott LJ (2003) Insulin glargine: an updated review of its use in the management of diabetes mellitus. Drugs 63:1743\u20131778","journal-title":"Drugs"},{"key":"112_CR72","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF03347452","volume":"30","author":"A Colao","year":"2007","unstructured":"Colao A, Arnaldi G, Beck-Peccoz P, Cannav\u00f2 S, Cozzi R, degli Uberti E, De Marinis L, De Menis E, Ferone D, Gasco V, Giustina A, Grottoli S, Lombardi G, Maffei P, Martino E, Minuto F, Pivonello R, Ghigo E (2007) Pegvisomant in acromegaly: why, when, how. J Endocrinol Invest 30:693\u2013699","journal-title":"J Endocrinol Invest"},{"key":"112_CR73","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/EJE-07-0637","volume":"158","author":"U Pl\u00f6ckinger","year":"2008","unstructured":"Pl\u00f6ckinger U, Reuter T (2008) Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study. Eur J Endocrinol 158:467\u2013471","journal-title":"Eur J Endocrinol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-009-0112-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-009-0112-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-009-0112-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T16:07:33Z","timestamp":1684944453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-009-0112-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,26]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["112"],"URL":"https:\/\/doi.org\/10.1007\/s00592-009-0112-9","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,26]]}}}